On May 20, 2022, Artelo Biosciences, Inc. closed the transaction. The company has received $96,972 in the transaction. The transaction included participation from a single investor.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.25 USD | -5.66% | -8.42% | -10.71% |
May. 13 | Artelo Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 23 | Transcript : Artelo Biosciences, Inc. - Special Call |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.71% | 4.28M | |
+14.84% | 122B | |
+18.31% | 113B | |
+3.61% | 22.66B | |
-18.26% | 21.34B | |
-41.55% | 16.92B | |
-14.23% | 16.68B | |
-16.03% | 16.61B | |
-0.68% | 13.62B | |
+21.87% | 11.04B |
- Stock Market
- Equities
- ARTL Stock
- News Artelo Biosciences, Inc.
- Artelo Biosciences, Inc. announced that it has received $0.9672 million in funding